Viatris Inc.

NASDAQ:VTRS

11.9 (USD) • At close September 19, 2024
Bedrijfsnaam Viatris Inc.
Symbool VTRS
Munteenheid USD
Prijs 11.9
Beurswaarde 14,202,888,000
Dividendpercentage 4.31%
52-weken bereik 8.74 - 13.62
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Scott Andrew Smith
Website https://www.viatris.com

An error occurred while fetching data.

Over Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious

Vergelijkbare Aandelen

BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc.

BMRN

71.41 USD

Bio-Techne Corporation logo

Bio-Techne Corporation

TECH

80.36 USD

Insulet Corporation logo

Insulet Corporation

PODD

237.68 USD

Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

ALNY

276.33 USD

Henry Schein, Inc. logo

Henry Schein, Inc.

HSIC

72.54 USD

Incyte Corporation logo

Incyte Corporation

INCY

66.82 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)